Diagnosis of Active Tuberculosis by ELISPOT

National Taiwan University Hospital200 enrolled

Overview

Recent studies revealed that the ex vivo enzyme-linked immunospot (ELISPOT) assay for gamma interferon is a specific method for contact tracing of Mycobacterium tuberculosis infection. However, its use in endemic area and bacillus Calmette-Guérin (BCG)-vaccinated hosts has not been proved. We hypothesize that the TB-ELISPOT assay can be a rapid and accurate diagnostic tool for active tuberculosis in clinical suspects in Taiwan.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Tuberculosis

Eligibility

Sex: ALLMin age: 0 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients who present with fever or respiratory symptoms (cough, dyspnea, or hemoptysis) lasting for ≥ 2 weeks and have compatible radiographic findings were considered clinical suspects of TB. Exclusion Criteria: \-

Locations (1)

National Taiwan University Hospital

Taipei, Taiwan

RECRUITING

Central Contacts

Jann-Yuan Wang, MD

CONTACT

886-2-23562905 jywang@ntu.edu.tw

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.